Combined oral contraceptives and antiretroviral PK/PD in Malawian women: pharmacokinetics and pharmacodynamics of a combined oral contraceptive and a generic combined formulation antiretroviral in Malawi
Stuart, G.S.; Moses, A.; Corbett, A.; Phiri, G.; Kumwenda, W.; Mkandawire, N.; Chintedze, J.; Malunga, G.; Hosseinipour, M.; Cohen, M.S.; Stanczyk, F.Z.; Kashuba, A.D.M.
Journal of Acquired Immune Deficiency Syndromes 58(2): E40-E43
2011
ISSN/ISBN: 1944-7884 PMID: 21921726 DOI: 10.1097/qai.0b013e31822b8bf8Document Number: 563514
Document emailed within 0-6 h
Related Documents
Landolt, N.K.; Phanuphak, N.; Ubolyam, S.; Pinyakorn, S.; Kriengsinyot, R.; Ahluwalia, J.; Thongpaeng, P.; Gorowara, M.; Thammajaruk, N.; Chaithongwongwatthana, S.; Lange, J.M.A.; Ananworanich, J. 2013: Efavirenz, in contrast to nevirapine, is associated with unfavorable progesterone and antiretroviral levels when coadministered with combined oral contraceptives Journal of Acquired Immune Deficiency Syndromes 62(5): 534-539Weisberg, E.; Merki-Feld, G.S.; McGeechan, K.; Fraser, I.S. 2015: Randomized comparison of bleeding patterns in women using a combined contraceptive vaginal ring or a low-dose combined oral contraceptive on a menstrually signaled regimen Contraception 91(2): 121-126
Konstantinus, I.N.; Balle, C.; Jaumdally, S.Z.; Galmieldien, H.; Pidwell, T.; Masson, L.; Tanko, R.F.; Happel, A.-U.; Sinkala, M.; Myer, L.; Bosinger, S.E.; Gill, K.; Bekker, L.-G.; Jaspan, H.B.; Passmore, J.-A.S. 2020: Impact of Hormonal Contraceptives on Cervical T-helper 17 Phenotype and Function in Adolescents: Results from a Randomized, Crossover Study Comparing Long-acting Injectable Norethisterone Oenanthate (NET-EN), Combined Oral Contraceptive Pills, and Combined Contraceptive Vaginal Rings Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 71(7): E76-E87
Minozzi, M.; Costantino, D.; Guaraldi, C.; Unfer, V. 2011: The effect of a combination therapy with myo-inositol and a combined oral contraceptive pill versus a combined oral contraceptive pill alone on metabolic, endocrine, and clinical parameters in polycystic ovary syndrome Gynecological Endocrinology: the Official Journal of the International Society of Gynecological Endocrinology 27(11): 920-924
Klipping, C.; Marr, J. 2005: Effects of two combined oral contraceptives containing ethinyl estradiol 20 μg combined with either drospirenone or desogestrel on lipids, hemostatic parameters and carbohydrate metabolism Contraception (Stoneham) 71(6): 409-416
Sivasubramanian, R.; Chakraborty, A.; Rouzade-Dominguez, M.-L.; Neelakantham, S.; Jakab, A.; Mensinga, T.; Legangneux, E.; Woessner, R.; Ufer, M. 2015: Effect of mavoglurant (AFQ056), a selective mGluR5 antagonist, on the pharmacokinetics of a combined oral contraceptive containing ethinyl estradiol and levonorgestrel in healthy women International Journal of Clinical Pharmacology and Therapeutics 53(7): 550-556
Gingnell, M.; Engman, J.; Frick, A.; Moby, L.; Wikström, J.; Fredrikson, M.; Sundström-Poromaa, I. 2013: Oral contraceptive use changes brain activity and mood in women with previous negative affect on the pill--a double-blinded, placebo-controlled randomized trial of a levonorgestrel-containing combined oral contraceptive Psychoneuroendocrinology 38(7): 1133-1144
Oner, G.; Muderris, I.I. 2011: A prospective randomized trial comparing low-dose ethinyl estradiol and drospirenone 24/4 combined oral contraceptive vs. ethinyl estradiol and drospirenone 21/7 combined oral contraceptive in the treatment of hirsutism Contraception 84(5): 508-511
Meyer, S. 2009: Contraceptive patch and vaginal ring vs. combined oral contraceptives American Family Physician 80(3): 232
Molina, R.C.; Sandoval, J.Z.; Montero, A.V.; Oyarzún, P.G.; Molina, T.ís.G.; González, E.A. 2009: Comparative performance of a combined injectable contraceptive (50 mg norethisterone enanthate plus 5mg estradiol valerate) and a combined oral contraceptive (0.15 mg levonorgestrel plus 0.03 mg ethinyl estradiol) in adolescents Journal of Pediatric and Adolescent Gynecology 22(1): 25-31
van Vliet, H.A.A.M.; Rosendaal, F.R.; Fleischer, K.; Rosing, J.; Helmerhorst, F.M. 2010: Effects of the contraceptive vaginal ring, the contraceptive transdermal patch and combined oral contraceptives on markers of hemostasis Contraception 81(1): 88-9; author reply 89-90
Agarwal, N.; Gupta, M.; Kriplani, A.; Bhatla, N.; Singh, N. 2016: Comparison of combined hormonal vaginal ring with ultralow-dose combined oral contraceptive pills in the management of heavy menstrual bleeding: a pilot study Journal of Obstetrics and Gynaecology: the Journal of the Institute of Obstetrics and Gynaecology 36(1): 71-75
Kuhnz, W.; al-Yacoub, G.; Fuhrmeister, A. 1992: Pharmacokinetics of levonorgestrel and ethinylestradiol in 9 women who received a low-dose oral contraceptive over a treatment period of 3 months and, after a wash-out phase, a single oral administration of the same contraceptive formulation Contraception 46(5): 455-469
Bifano, M.; Sevinsky, H.; Hwang, C.; Kandoussi, H.; Jiang, H.; Grasela, D.; Bertz, R. 2014: Effect of the coadministration of daclatasvir on the pharmacokinetics of a combined oral contraceptive containing ethinyl estradiol and norgestimate Antiviral Therapy 19(5): 511-519
Boonsiri, B.; Kolkijkovinda, S.; Chutivongse, S.; Crona, N.; Medberg, M.; Gundersen, G.; Samsioe, G.; Garza-Flores, J.; Valles de Bourges, V.; Juarez-Ayala, J. 1988: A multicentre comparative study of serum lipids and lipoproteins in four groups of oral combined contraceptive users and a control group of IUD users. World Health Organization. Task Force on Oral Contraceptives Contraception 38(6): 605-629
Bellod, P.; Serrano, C.; Díaz, A.; Tejero, T.; Nuño, J.; de Oya, M. 1983: Changes in serum lipoproteins in women treated with combined oral contraceptives Revista Clinica Espanola 170(6): 275-278
De Leo, V.; Scolaro, V.; Musacchio, M.C.; Di Sabatino, A.; Morgante, G.; Cianci, A. 2011: Combined oral contraceptives in women with menstrual migraine without aura Fertility and Sterility 96(4): 917-920
Wong, M.T.; Singh, K. 2003: The combined oral contraceptive pill in women over age forty Annals of the Academy of Medicine Singapore 32(5): 624-631
Wei, W.; Li, Y.; Chen, F.; Chen, C.; Sun, T.; Sun, Z.; Wu, Y.; Zhou, J.; Ba, L. 2011: Dyslipidaemia, combined oral contraceptives use and their interaction on the risk of hypertension in Chinese women Journal of Human Hypertension 25(6): 364-371
Vaisy, A.; Lotfinejad, S.; Zhian, F. 2014: Risk of cancer with combined oral contraceptive use among Iranian women Asian Pacific Journal of Cancer Prevention: Apjcp 15(14): 5517-5522